These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 314248

  • 1. Levamisole in systemic lupus erythematosus.
    Ogawa K, Sano T, Hisano G, Tsubura E.
    Ann Allergy; 1979 Sep; 43(3):187-9. PubMed ID: 314248
    [Abstract] [Full Text] [Related]

  • 2. Levamisole maintains cyclophsophamide-induced remission in murine lupus erythematosus.
    Zulman J, Michalski J, McCombs C, Greenspan J, Talal N.
    Clin Exp Immunol; 1978 Feb; 31(2):321-7. PubMed ID: 306328
    [Abstract] [Full Text] [Related]

  • 3. [Clinical experience with levamisole treatment of patients with systemic lupus erythematosus (author's transl)].
    Scherak O, Smolen J, Kolarz G, Kojer M, Menzel J.
    Wien Klin Wochenschr; 1979 Nov 23; 91(22):758-62. PubMed ID: 160142
    [Abstract] [Full Text] [Related]

  • 4. Treatment of systemic lupus erythematosus with the T-cell immunopotentiator levamisole: a follow-up report of 16 patients under treatment for a minimum period of four months.
    Gordon BL, Yanagihara R.
    Ann Allergy; 1977 Oct 23; 39(4):227-36. PubMed ID: 71868
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lupus nephritis: clinical course in relation to treatment.
    Nanra RS, Kincaid-Smith P.
    Perspect Nephrol Hypertens; 1973 Oct 23; 1 Pt 2(0):1193-210. PubMed ID: 4803309
    [No Abstract] [Full Text] [Related]

  • 11. [Effects of levamisole in lupus nephritis].
    Horiuchi A.
    Nihon Jinzo Gakkai Shi; 1979 Apr 23; 21(4):280-3. PubMed ID: 480701
    [No Abstract] [Full Text] [Related]

  • 12. Chronic lupus erythematosus: observations on long-term survivors of "suppressive" therapy of lupus nephritis with prednisolone.
    Mackay IR.
    Perspect Nephrol Hypertens; 1973 Apr 23; 1 Pt 2(0):1211-7. PubMed ID: 4139686
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of levamisole (Decaris) on various immunologic parameters in patients with systemic lupus erythematosus].
    Gandzha IM, Sakharchuk VM, Lysenko GI.
    Ter Arkh; 1981 Apr 23; 53(7):121-4. PubMed ID: 6457406
    [No Abstract] [Full Text] [Related]

  • 17. [Serum anti-dsDNA antibodies in lupus nephritis].
    Fiorentini GP, Cagnoli L.
    Boll Soc Ital Biol Sper; 1981 Sep 30; 57(18):1890-5. PubMed ID: 7032540
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients.
    Michalevicz R, Many A, Ramot B, Trainin N.
    Clin Exp Immunol; 1978 Jan 30; 31(1):111-5. PubMed ID: 639342
    [Abstract] [Full Text] [Related]

  • 20. [Therapy of lupus nephritis in childhood].
    Taubert M, Döring E.
    Padiatr Grenzgeb; 1983 Jan 30; 22(2-3):191-4. PubMed ID: 6888932
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.